{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T01:10:02Z","timestamp":1722388202216},"reference-count":1,"publisher":"American Psychiatric Association Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[1995,3,1]]},"DOI":"10.1176\/ajp.152.3.471a","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T19:49:00Z","timestamp":1418845740000},"page":"471a-471","source":"Crossref","is-referenced-by-count":2,"title":["Fibrocystic breast disease following treatment with selective serotonin reuptake inhibitors"],"prefix":"10.1176","volume":"152","member":"230","reference":[{"key":"p_1","first-page":"253","volume":"28","author":"Brown WA","year":"1992","journal-title":"Psychopharmacol Bull"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.152.3.471a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:43:37Z","timestamp":1722386617000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/ajp.152.3.471a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3,1]]},"references-count":1,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,3,1]]}},"alternative-id":["10.1176\/ajp.152.3.471a"],"URL":"https:\/\/doi.org\/10.1176\/ajp.152.3.471a","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"type":"print","value":"0002-953X"},{"type":"electronic","value":"1535-7228"}],"subject":[],"published":{"date-parts":[[1995,3,1]]}}}